AAFP: Keep REMS continuing medical education voluntary

08/1/2013 | AAFP News Now

Prescribers should be involved in deciding whether and how risks of certain classes of drugs and biologics will be mitigated in risk evaluation and mitigation strategies, the AAFP's Ann Karty, M.D., told an FDA meeting on the challenges of REMS standardization and assessment. Karty, who presented information on REMS requirements for extended-release and long-acting opioids, said that REMS continuing medical education should remain voluntary for prescribers and that mandating CME could create confusion for physicians and limit patient access to drugs.

View Full Article in:

AAFP News Now

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN